Agilent Technologies (A): financials, SEC filings and peers
Agilent Technologies (A) is a life sciences tools & services company in the Health Care sector of the S&P 500, headquartered in Santa Clara, California.
It was founded in 1999 and joined the S&P 500 on June 5, 2000.
Its fiscal year ends in October, and its shares trade on the NYSE.
In its SEC filings it is classified as “Laboratory Analytical Instruments”.
Agilent Technologies at a glance
- Revenue (12 months)
- $7.4B
- Revenue growth
- +8.6%
- Operating margin
- 22.2%
- Net income (12 months)
- $1.4B
- Free cash flow (12 months)
- $1.3B
- Cash
- $1.8B
- Debt
- $3.9B
- Diluted EPS (12 months)
- $5.07
Twelve months to July 31, 2026, from the 10-Q filed September 1, 2026.
Latest twelve months
Over the twelve months to July 31, 2026, Agilent Technologies reported revenue of $7.4 billion, up 8.6% from a year earlier.
Its operating margin was 22.2%: for every $100 of sales, about $22 was left as operating profit.
Net income was $1.4 billion (19.5% of revenue), 18.0% higher than a year earlier.
Operating cash flow was $1.6 billion and capital spending $342 million, leaving free cash flow of $1.3 billion (17.2% of revenue).
At the end of the period it held $1.8 billion in cash and $3.9 billion in debt, a net debt position of $2.2 billion.
Five-year trend
- Revenue went from $5.3 billion in fiscal 2020 to $6.9 billion in fiscal 2025, about 5.4% a year.
- Operating margin widened from 15.8% to 21.3% over the same years.
- Free cash flow was positive in each of the last 6 fiscal years.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $6.3B | $6.8B | $6.8B | $6.5B | $6.9B |
| Revenue growth | 18.4% | 8.4% | -0.2% | -4.7% | 6.7% |
| Operating margin | 21.3% | 23.6% | 19.8% | 22.9% | 21.3% |
| Net income | $1.2B | $1.3B | $1.2B | $1.3B | $1.3B |
| Free cash flow | $1.3B | $1.0B | $1.5B | $1.4B | $1.2B |
| Diluted EPS | $3.94 | $4.18 | $4.19 | $4.43 | $4.57 |
Fiscal years as reported in Agilent Technologies’s 10-K filings. Free cash flow is operating cash flow minus capital spending.
Recent SEC filings
- 8-K filed September 8, 2026 — Executive or director change; Regulation FD disclosure
- 10-Q filed September 1, 2026 — quarterly report
- 8-K filed August 26, 2026 — Earnings results
- 8-K filed June 25, 2026 — Material agreement; New debt obligation
- 10-Q filed June 1, 2026 — quarterly report
- 8-K filed May 27, 2026 — Earnings results; Executive or director change
- 8-K filed May 4, 2026 — Executive or director change; Regulation FD disclosure
- 8-K/A filed April 6, 2026 — Executive or director change
Companies like Agilent Technologies
Other S&P 500 companies in Life Sciences Tools & Services:
- CRLCharles River LaboratoriesWilmington, Massachusetts
- DHRDanaher CorporationWashington, D.C.
- ILMNIllumina, Inc.San Diego, California
- IQVIQVIADurham, North Carolina
- MTDMettler ToledoColumbus, Ohio
- TECHBio-TechneMinneapolis, Minnesota
- TMOThermo Fisher ScientificWaltham, Massachusetts
- WATWaters CorporationMilford, Massachusetts
More from Health Care
Questions about Agilent Technologies
Is Agilent Technologies's revenue growing?
Yes. Revenue for the twelve months to July 31, 2026 was $7.4 billion, up 8.6% from a year earlier, according to its SEC filings.
Is Agilent Technologies profitable?
Yes. It earned $1.4 billion in net income over the twelve months to July 31, 2026, a net margin of 19.5%.
Does Agilent Technologies have more cash or more debt?
At July 31, 2026 it had $1.8 billion in cash and $3.9 billion in debt, so more debt than cash.
When did Agilent Technologies last file financial results?
Its latest quarterly report (10-Q) was filed with the SEC on September 1, 2026.
Which companies are similar to Agilent Technologies?
In the S&P 500, Agilent Technologies is grouped in Life Sciences Tools & Services within the Health Care sector. Charles River Laboratories (CRL), Danaher Corporation (DHR), Illumina, Inc. (ILMN), IQVIA (IQV), Mettler Toledo (MTD) are in the same group.
Understand the numbers
Source: Agilent Technologies’s filings with the U.S. Securities and Exchange Commission (EDGAR), retrieved September 27, 2026. Figures are as reported by the company and may be restated. This page is for information only and is not financial advice.